Research shows people with HIV on effective treatment develop COVID-19 immune responses comparable to the general population after booster vaccination.
Exploring how HIV-1's tiny Vpr protein hijacks human cells through sophisticated molecular mechanisms.
Groundbreaking research reveals how mucosal mast cells act as undercover accomplices in HIV transmission, capturing and delivering the virus directly to vulnerable T cells.
Exploring the pivotal 1989 clinical trial that tested dideoxycytidine (ddC) and measured its impact through p24 levels—a study whose legacy resonates in today's cutting-edge HIV diagnostics.